Infusion Services at Smart Infusion Therapy

Infusion Therapy for RA, Psoriatic Arthritis & More

Infusion therapy is a valuable treatment option for many types of rheumatological conditions. Infusion therapy is the administration of medication in a controlled manner via IV or injection for effective results. 

At Smart Infusion Therapy Services, we specialize in infusion therapy treatments for various types of arthritis, including the following:

Rheumatoid Arthritis (RA) & Psoriatic Arthritis (PSA)

Infusion therapy for rheumatoid arthritis and psoriatic arthritis can provide relief from the chronic inflammation associated with these conditions, helping to reduce joint pain and stiffness.

• Cimzia: Cimzia (certolizumab pegol) is a subcutaneous injection prescribed for the treatment of rheumatoid and psoriatic arthritis. It works by blocking certain proteins that cause the disease and helps reduce the symptoms of joint pain, swelling,  stiffness, and skin manifestations experienced with arthritis. 
• Remicade: Remicade (infliximab) is an intravenous medication prescribed to treat moderate to severe rheumatoid arthritis, psoriatic arthritis, and other autoimmune diseases. This drug works by blocking proteins that are associated with inflammation, helping to relieve symptoms such as joint pain and stiffness while also slowing down disease progression. 
• Ruxience: Ruxience (tocilizumab-aqqg biosimilar of rituximab) is an intravenous medication used in the treatment of active rheumatoid arthritis in adults. It helps reduce signs and symptoms of the disease, such as pain and swelling, while also slowing its progression. This drug works by preventing B-cells from producing inflammatory molecules.
• Avsola: Avsola (infliximab-axxq, mavrilimumab remicade biosimilar) is a medication that helps reduce signs and symptoms of active rheumatoid arthritis and psoriatic arthritis in adults when taken alongside other medications for the same condition. Avsola prevents cells from producing inflammatory molecules, helping to slow down disease progression while also relieving pain and swelling associated with RA and PsA. 
• Truxima: Truxima (rituximab-abbs biosimilar) is a therapy used to treat moderate to severe cases of rheumatoid arthritis in adults who have not responded adequately to other treatments for the same conditions. This drug works by preventing B-cells from producing inflammatory molecules.
• Inflectra: Inflectra (infliximab-dyyb, biosimilar of Remicade) is a biologic therapy that can help reduce inflammation caused by rheumatoid and psoriatic arthritis, thus relieving pain, stiffness, swelling, and skin manifestations associated with these conditions while also slowing their progression over time.
• Actemra: Actemra (tocilizumab) is a medication prescribed for treating active cases of moderate-to-severe adult rheumatoid arthritis. Actemra works by preventing cells from producing inflammatory molecules via blocking IL-6 which helps reduce signs and symptoms such as pain, swelling, fatigue as well as slow disease activity over time.
• Orencia: Orencia (abatacept) is a medication used for treating adult patients suffering from moderate-to-severe RA or PsA. It reduces inflammation associated with RA and PsA, making it easier for patients to move more freely without feeling much discomfort due to joint stiffening or swelling. This drug works by preventing B-cells from producing inflammatory molecules.
• Rituxan: Rituxan (rituximab) is a biologic therapy employed in treating moderate-to-severe adult cases of rheumatoid arthritis who have failed previous therapies. It works by inhibiting certain white blood cells which help lower levels of inflammations leading up reduced joint swelling and stiffness. This drug works by preventing B-cells from producing inflammatory molecules.
• Simponi Aria: Simponi Aria (golimumab) is an intravenous medication for treating moderately-to-severely active RA and PsA in adult patients. It prevents the immune system from attacking joint tissues, thus helping bring down inflammation levels, pain, stiffness, and skin manifestations.
• Renflexis: Renflexis (infliximab-adba, Remicade biosimilar) is an intravenous therapy used for managing moderate-to-severe adult RA and PsA. It prevents the immune system from attacking joint tissues, thus helping bring down inflammation levels, pain, stiffness, and skin manifestations.

Gout

IV infusion therapy delivers medications that can help relieve the pain associated with gout and reduce inflammation.

• Krystexxa: Krystexxa (pegloticase) is an intravenous medication designed to treat severe cases of tophaceous gout in adults that have failed other treatments. This medication works by breaking down uric acid crystals that form in the joints and cause inflammation, pain, and swelling associated with gout. Krystexxa is administered every two weeks or as prescribed by your doctor based on your condition and response to treatment.

Lupus (Systemic Lupus Erythematosus, SLE)

IV treatments can help reduce inflammation and improve overall symptoms of lupus. 

• Saphnelo is an IV infusion medication used to treat adult patients with active, autoantibody-positive systemic lupus erythematosus (SLE). It blocks interferons which cause inflammation and symptoms of SLE.
• Benlysta is an IV infusion therapy approved for the treatment of adult and pediatric patients aged 5 years and older with active lupus nephritis or SLE. It blocks B cell production which is responsible for the inflammation and symptoms of SLE.

Ankylosing Spondylitis (AS)

Infusion therapy can help reduce inflammation and improve mobility in those suffering from ankylosing spondylitis.

• Cimzia: Cimzia (certolizumab pegol) is a subcutaneous injection medication for the treatment of ankylosing spondylitis in adults. This drug works by blocking certain proteins that cause the disease and helps reduce signs and symptoms such as pain, stiffness, and swelling.
• Remicade: Remicade (infliximab) is an intravenous medication used to treat moderate-to-severe cases of ankylosing spondylitis in adults. This drug works by blocking proteins that cause inflammation, thereby reducing pain, stiffness, and swelling while also slowing down disease progression. 
• Avsola: Avsola (infliximab-axxq, mavrilimumab remicade biosimilar) is an IV medication used in treating active cases of ankylosing spondylitis in adults. Avsola prevents cells from producing inflammatory molecules which helps reduce signs and symptoms of the disease while also slowing its progression over time. 
• Inflectra: Inflectra (infliximab-dyyb Remicade biosimilar) is an IV therapy that can help reduce inflammation caused by ankylosing spondylitis, thus relieving pain, stiffness, and swelling associated with this condition while also slowing its progression over time. 
• Simponi Aria: Simponi Aria (golimumab) is an IV therapy used to treat moderate-to-severe cases of ankylosing spondylitis in adult patients. It acts as a blockade, preventing the immune system from attacking healthy joint tissues, thereby reducing inflammation levels and relieving related pain and stiffness.
• Renflexis: Renflexis (infliximab-adba, Remicade biosimilar) is an IV therapy used to manage moderate-to-severe adult cases of ankylosing spondylitis. This therapy works by targeting and blocking specific proteins involved in inflammation, thus restoring balance within the immune system.

Our team is experienced in administering infusion therapy treatments for each of these conditions, and we understand that every patient’s needs are unique. We take the time to get to know you while following your doctor’s orders.